Joshua Richter, MD, Assistant Professor of Medicine (Hematology and Medical Oncology); Icahn School of Medicine at Mount Sinai; Site Director of Myeloma Services, Chelsea; Center of Excellence for Multiple Myeloma
Dr. Richter discusses special concerns for multiple myeloma patients during the COVID-19 pandemic and treatment modifications to minimize exposure.
ADVERTISEMENT
